Sudo Biosciences Doses First Participants in TYK2 Inhibitor Trial
02 Dec 2024 //
BUSINESSWIRE
Sudo Biosciences Announces Second Close of Upsized Series B Financing
13 Feb 2024 //
BUSINESSWIRE
02 Dec 2024 //
BUSINESSWIRE
13 Feb 2024 //
BUSINESSWIRE